Artivion director Anthony Semedo acquires shares worth $53,140

Published 05/03/2025, 22:04
Artivion director Anthony Semedo acquires shares worth $53,140

Anthony B. Semedo, a director at Artivion, Inc. (NYSE:AORT), recently acquired a notable amount of the company’s common stock. According to the latest SEC filing, Semedo purchased a total of 2,100 shares on March 5, 2025, in two separate transactions. The shares were bought at prices ranging from $25.25 to $25.327 per share, amounting to a total value of approximately $53,140. According to InvestingPro data, the stock’s RSI suggests oversold conditions, while the company maintains strong liquidity with a current ratio of 4.34x.

The transactions included 1,500 shares acquired directly by Mr. Semedo, intended for his IRA, and an additional 600 shares purchased indirectly through his spouse’s IRA. Post-transaction, Mr. Semedo’s direct ownership in Artivion stands at 35,659 shares, while the shares held indirectly by his spouse amount to 600. The company, with a market capitalization of $1.07 billion, has demonstrated revenue growth of 9.75% in the last twelve months.

These acquisitions reflect Semedo’s continued investment in Artivion, a company specialized in the surgical and medical instruments sector. InvestingPro analysis reveals analyst targets ranging from $30 to $35, with net income expected to grow this year. Get access to 10+ additional ProTips and comprehensive financial analysis with an InvestingPro subscription.

In other recent news, Artivion Inc. reported its fourth-quarter revenue for 2024 at $97.3 million, which fell short of the anticipated $100.82 million. This shortfall was largely due to a cybersecurity breach that impacted sales by approximately $4.5 million. Despite this, Artivion’s adjusted EBITDA for the quarter exceeded expectations, reaching $17.6 million compared to the forecasted $17 million. The company’s full-year revenue for 2024 also did not meet expectations, totaling $388.5 million against the guidance range of $389 million to $396 million. Looking ahead, Artivion projects 2025 revenue to be between $420 million and $435 million, representing a 10-14% growth. Analysts from Stifel, Needham, and JMP Securities have adjusted their price targets for Artivion, with Stifel lowering it to $30, Needham to $32, and JMP maintaining it at $33, all while keeping a Buy or Market Outperform rating. The cybersecurity incident is expected to affect the first quarter of 2025, with projected revenues between $94 million and $98 million, below prior estimates. Despite these challenges, Artivion anticipates a rebound in sales growth throughout 2025, with adjusted EBITDA expected to reach between $83 million and $91 million.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.